155 related articles for article (PubMed ID: 8790853)
21. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
[TBL] [Abstract][Full Text] [Related]
22. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
[TBL] [Abstract][Full Text] [Related]
23. Ureteral stent placement without postprocedural nephrostomy tube: experience in 41 patients.
Patel U; Abubacker MZ
Radiology; 2004 Feb; 230(2):435-42. PubMed ID: 14688404
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (Uventa™) in malignant ureteral obstructions.
Chung KJ; Park BH; Park B; Lee JH; Kim WJ; Baek M; Han DH
J Endourol; 2013 Jul; 27(7):930-5. PubMed ID: 23590584
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction.
Asakawa J; Iguchi T; Tamada S; Ninomiya N; Kato M; Yamasaki T; Nakatani T
Int J Urol; 2018 Mar; 25(3):258-262. PubMed ID: 29194771
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction.
Alma E; Ercil H; Vuruskan E; Altunkol A; Unal U; Gurlen G; Goren V; Gurbuz ZG
Support Care Cancer; 2020 Nov; 28(11):5581-5588. PubMed ID: 32757161
[TBL] [Abstract][Full Text] [Related]
27. Use of full-length metallic stents in malignant ureteral obstruction.
Abbasi A; Wyre HW; Ogan K
J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
[TBL] [Abstract][Full Text] [Related]
28. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
[TBL] [Abstract][Full Text] [Related]
29. Ureteral obstruction associated with prostate cancer: the outcome after percutaneous nephrostomy.
Chiou RK; Chang WY; Horan JJ
J Urol; 1990 May; 143(5):957-9. PubMed ID: 2329611
[TBL] [Abstract][Full Text] [Related]
30. Malignant ureteral obstruction: outcomes after intervention. Have things changed?
Wong LM; Cleeve LK; Milner AD; Pitman AG
J Urol; 2007 Jul; 178(1):178-83; discussion 183. PubMed ID: 17499300
[TBL] [Abstract][Full Text] [Related]
31. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi.
Pearle MS; Pierce HL; Miller GL; Summa JA; Mutz JM; Petty BA; Roehrborn CG; Kryger JV; Nakada SY
J Urol; 1998 Oct; 160(4):1260-4. PubMed ID: 9751331
[TBL] [Abstract][Full Text] [Related]
32. Endourologic management of severely encrusted ureteral stents.
Lojanapiwat B
J Med Assoc Thai; 2005 Sep; 88(9):1203-6. PubMed ID: 16536105
[TBL] [Abstract][Full Text] [Related]
33. Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction.
Modi AP; Ritch CR; Arend D; Walsh RM; Ordonez M; Landman J; Gupta M; Knudsen BE
J Endourol; 2010 Jul; 24(7):1189-93. PubMed ID: 20575695
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous nephrostomy in the management of advanced and terminal-stage gynecologic malignancies: outcome and complications.
Plesinac-Karapandzic V; Masulovic D; Markovic B; Djuric-Stefanovic A; Plesinac S; Vucicevic D; Milovanovic Z; Milosevic Z
Eur J Gynaecol Oncol; 2010; 31(6):645-50. PubMed ID: 21319508
[TBL] [Abstract][Full Text] [Related]
35. Antegrade retrieval of ureteral stents through an 8-French percutaneous nephrostomy route.
Liang HL; Yang TL; Huang JS; Lin YH; Chou CP; Chen MC; Pan HB
AJR Am J Roentgenol; 2008 Nov; 191(5):1530-5. PubMed ID: 18941096
[TBL] [Abstract][Full Text] [Related]
36. The Role of Tandem Double-J Ureteral Stents in the Management of Malignant Ureteral Obstruction.
Varnavas M; Bolgeri M; Mukhtar S; Anson K
J Endourol; 2016 Apr; 30(4):465-8. PubMed ID: 26585189
[TBL] [Abstract][Full Text] [Related]
37. Metallic ureteral stents in malignant ureteral obstruction: clinical factors predicting stent failure.
Chow PM; Hsu JS; Huang CY; Wang SM; Lee YJ; Huang KH; Yu HJ; Pu YS; Liang PC
J Endourol; 2014 Jun; 28(6):729-34. PubMed ID: 24397490
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
Ekici S; Sahin A; Ozen H
J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
[TBL] [Abstract][Full Text] [Related]
39. Urologic-Induced Complications of Prophylactic Ureteral Localization Stent Placement for Colorectal Surgery Cases.
Pathak RA; Taylor AS; Alford S; Broderick GA; Igel TC; Petrou SP; Wehle MJ; Young PR; Thiel DD
J Laparoendosc Adv Surg Tech A; 2015 Dec; 25(12):966-70. PubMed ID: 26583763
[TBL] [Abstract][Full Text] [Related]
40. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
